| Product NDC: | 0143-9674 |
| Proprietary Name: | Argatroban |
| Non Proprietary Name: | Argatroban |
| Active Ingredient(s): | 250 mg/2.5mL & nbsp; Argatroban |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0143-9674 |
| Labeler Name: | West-ward Pharmaceutical Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203049 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120105 |
| Package NDC: | 0143-9674-01 |
| Package Description: | 2.5 mL in 1 VIAL (0143-9674-01) |
| NDC Code | 0143-9674-01 |
| Proprietary Name | Argatroban |
| Package Description | 2.5 mL in 1 VIAL (0143-9674-01) |
| Product NDC | 0143-9674 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Argatroban |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120105 |
| Marketing Category Name | NDA |
| Labeler Name | West-ward Pharmaceutical Corp |
| Substance Name | ARGATROBAN |
| Strength Number | 250 |
| Strength Unit | mg/2.5mL |
| Pharmaceutical Classes | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |